11![Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w](https://www.pdfsearch.io/img/2788ab3e6e61954d54953524b7c506c4.jpg) | Add to Reading ListSource URL: www.astrazeneca.caLanguage: English - Date: 2017-11-11 05:51:44
|
---|
12![Community Support Contributions: 2012 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2012, we invested almost $16 million in health initiatives Community Support Contributions: 2012 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2012, we invested almost $16 million in health initiatives](https://www.pdfsearch.io/img/d8dd85ce1ca267100a86b0cba4740726.jpg) | Add to Reading ListSource URL: www.astrazeneca.caLanguage: English - Date: 2017-11-16 21:16:49
|
---|
13![PRESS RELEASE Gothenburg 17th of January 2018, 16:15 CELLINK establishes R&D lab in AstraZeneca’s BioVentureHub New lab to specialize in oncology research, as well as bioprinted lung and heart tissue models PRESS RELEASE Gothenburg 17th of January 2018, 16:15 CELLINK establishes R&D lab in AstraZeneca’s BioVentureHub New lab to specialize in oncology research, as well as bioprinted lung and heart tissue models](https://www.pdfsearch.io/img/17a04d29310070d9a17209aa9aad75ed.jpg) | Add to Reading ListSource URL: mb.cision.comLanguage: English - Date: 2018-01-17 10:38:43
|
---|
14![Growth factor GPCR Ligand Growth factor GPCR Ligand](https://www.pdfsearch.io/img/ba57bee78cbf64063c099e82921d57e1.jpg) | Add to Reading ListSource URL: www.astrazeneca.com- Date: 2017-11-07 12:40:23
|
---|
15![LUPUS PATIENTS EXPERIENCE INADEQUATE SYMPTOM CONTROL DESPITE TREATMENT1 Despite recent therapeutic advances improving patient outcomes, many patients still face: 1 LUPUS PATIENTS EXPERIENCE INADEQUATE SYMPTOM CONTROL DESPITE TREATMENT1 Despite recent therapeutic advances improving patient outcomes, many patients still face: 1](https://www.pdfsearch.io/img/eb3cb2a26f5a0f3b3f56a2afdc33e611.jpg) | Add to Reading ListSource URL: www.astrazeneca.comLanguage: English - Date: 2017-11-08 12:53:23
|
---|
16![](/pdf-icon.png) | Add to Reading ListSource URL: ctep.cancer.govLanguage: English - Date: 2018-04-25 11:12:49
|
---|
17![MYTH Only affects women versus REALITY in LUPUS MYTH Only affects women versus REALITY in LUPUS](https://www.pdfsearch.io/img/434a3001d6d7e7e40484ea72f384f5d3.jpg) | Add to Reading ListSource URL: www.astrazeneca.comLanguage: English - Date: 2017-11-07 12:42:20
|
---|
18![Community Support Contributions: 2013 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2013, we invested more than $6 million in health initiative Community Support Contributions: 2013 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2013, we invested more than $6 million in health initiative](https://www.pdfsearch.io/img/c7c1dfb9c2e787c3c8a7112ef01ba0a1.jpg) | Add to Reading ListSource URL: www.astrazeneca.caLanguage: English - Date: 2017-11-11 05:52:14
|
---|
19![SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) CAN CAUSE PERMANENT CUMULATIVE ORGAN DAMAGE1,2 More than half of SLE patients develop permanent organ system damage which could lead to increased morbidity and mortality1,3 Damage is m SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) CAN CAUSE PERMANENT CUMULATIVE ORGAN DAMAGE1,2 More than half of SLE patients develop permanent organ system damage which could lead to increased morbidity and mortality1,3 Damage is m](https://www.pdfsearch.io/img/bf21d0c6620b8ab06e2b91d823a09d81.jpg) | Add to Reading ListSource URL: www.astrazeneca.comLanguage: English - Date: 2017-11-07 20:52:46
|
---|
20![](https://www.pdfsearch.io/img/9d4d2858fd47760b4d27a2c76bd3a451.jpg) | Add to Reading ListSource URL: www.astrazeneca.com- Date: 2017-11-07 22:42:49
|
---|